Weight Loss Drug Stocks: Biotech Breakthrough or Market Bubble?
The episode discusses the weight loss drug sector, focusing on Novo Nordisk's strategy with Wegovy and the intensifying competition. It also touches on various stocks including Berkshire Hathaway, Snap Inc., and others.